Current Problems in Cancer
Volume 31, Issue 3 , Pages 202-210 , May 2007

Racial Disparities in Lung Cancer

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
  2. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975-2002.
  3. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407–1427
  4. Marshall L, Schooley M, Ryan H, Cox P, Easton A, Healton C, et al. Youth tobacco surveillance—United States, 2001-2002. MMWR Surveill Summ. 2006;55:1–56
  5. Singh GK, Miller BA, Hankey BF. EBK: Area Socioeconomic Variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975-1999. NCI Cancer Surveillance Monograph Series Number 4, 2006.
  6. Giovino GA. Epidemiology of tobacco use in the United States. Oncogene. 2002;21(48):7326–7340
  7. Perez-Stable EJ, Herrera B, Jacob P, Benowitz NL. Nicotine metabolism and intake in black and white smokers. J Am Med Assoc. 1998;280:152–156
  8. Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob P. Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther. 1999;291:1196–1203
  9. Risch N. Dissecting racial and ethnic differences. N Engl J Med. 2006;354:408–411
  10. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354:333–342
  11. Shields PG. Tobacco smoking, harm reduction, and biomarkers. J Natl Cancer Inst. 2002;94:1435–1444
  12. Akerley WL, Moritz TE, Ryan LS, Henderson WG, Zacharski LR. Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer. Arch Intern Med. 1993;153:1681–1688
  13. Blackstock AW, Herndon JE, Paskett ED, Miller AA, Lathan C, Niell HB, et al. Similar outcomes between African American and non-African American. J Clin Oncol. 2006;24:407–412
  14. Brawley OW. Lung cancer and race: equal treatment yields equal outcome among equal. J Clin Oncol. 2006;24:332–333
  15. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung. J Clin Oncol. 2006;24:413–418
  16. Smith TJ, Penberthy L, Desch CE, Whittemore M, Newschaffer C, Hillner BE, et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer. 1995;13:235–252
  17. Fry WA, Menck HR, Winchester DP. The National Cancer Data Base report on lung cancer. Cancer. 1996;77:1947–1955
  18. Greenwald HP, Polissar NL, Borgatta EF, McCorkle R, Goodman G. Social factors, treatment, and survival in early-stage non-small cell lung. Am J Public Health. 1998;88:1681–1684
  19. Polednak AP. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 2000;342:517–518
  20. McWhorter WP, Schatzkin AG, Horm JW, Brown CC. Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer. 1989;63:982–987
  21. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198–1205
  22. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. J Am Med Assoc. 2002;287:2106–2113
  23. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351:575–584
  24. Blackstock AW, Herndon JE, Paskett ED, Miller AA, Lathan C, Niell HB, et al. Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B. J Clin Oncol. 2006;24:407–412
  25. Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, et al. Who gets chemotherapy for metastatic lung cancer?. Chest. 2000;117:1239–1246
  26. Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol. 2002;20:1786–1792
  27. True G, Phipps EJ, Braitman LE, Harralson T, Harris D, Tester W. Treatment preferences and advance care planning at end of life: the role. Ann Behav Med. 2005;30:174–179
  28. Margolis ML, Christie JD, Silvestri GA, Kaiser L, Santiago S, Hansen-Flaschen J. Racial differences pertaining to a belief about lung cancer surgery. Ann Intern Med. 2003;139:558–563

 Supported by Grant P60MD000525 from the National Center for Minority Health and Health Disparities, NIH

PII: S0147-0272(07)00009-8

doi: 10.1016/j.currproblcancer.2007.02.002

Current Problems in Cancer
Volume 31, Issue 3 , Pages 202-210 , May 2007

Article Tools